(Q69442750)

English

Evidence that treatment with vaccinia melanoma cell lysates (VMCL) may improve survival of patients with stage II melanoma. Treatment of stage II melanoma with viral lysates

scientific article published on 01 January 1987

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677126%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

Evidence that treatment with vaccinia melanoma cell lysates (VMCL) may improve survival of patients with stage II melanoma. Treatment of stage II melanoma with viral lysates (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677126%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

author name string

P Hersey

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677126%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

A Edwards

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677126%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

A Coates

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677126%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

H Shaw

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677126%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

W McCarthy

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677126%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

G Milton

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677126%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

publication date

1 January 1987

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677126%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677126%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677126%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677126%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

257-265

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3677126%20AND%20SRC:MED&resulttype=core&format=json

2 October 2019

https://scigraph.springernature.com/pub.10.1007/bf00199156

0 references

Non-Randomized Controls in Cancer Clinical Trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNCB reactivity and prognosis in 419 patients with malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of vaccinia melanoma cell lysates (VMCL) as adjuvant to surgical treatment of stage II melanoma. II. Effects on cell mediated cytotoxicity and leucocyte dependent antibody activity: immunological effects of VMCL in melanoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human melanoma antigen AH is an autoantigenic ganglioside related to GD2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized versus historical controls for clinical trials.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new approach in specific, active immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current status and future prospects for adjuvant therapy of melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccinia virus proteins on the plasma membranes of infected cells. II. Expression of viral antigens and killing of infected cells by vaccinia virus-specific cytotoxic T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SOME METHODS USED IN THE MANAGEMENT OF METASTATIC MALIGNANT MELANOMA

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgical adjuvant therapy of malignant melanoma with corynebacterium parvum

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Virus Augmentation of The Antigenicity of Tumor Cell

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Localization at high resolution of antibody-induced mobilization of vaccinia virus hemagglutinin and the major histocompatibility antigens on the plasma membrane of infected cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review of melanoma antigens recognized by monoclonal antibodies (MAbs). Their functional significance and applications in diagnosis and treatment of melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural killer cell cytotoxic potential of patients with ovarian carcinoma and its modulation with virus-modified tumor cell extract

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human malignant melanoma cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study on the postsurgical management of Stage II malignant melanoma with a Newcastle disease virus oncolysate

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant immunotherapy of malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A cytogenetic study of eight human melanoma cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VITILIGO IN A CASE OF VACCINIA VIRUS-TREATED MELANOMA.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II)

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of BCG adjuvant immunotherapy for melanoma of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serologic response to human melanoma lines from patients with melanoma undergoing treatment with vaccinia melanoma oncolysates

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of leukocyte-dependent antibody activity in melanoma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy of Malignant Melanoma With Vaccinia Virus

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized controlled trial of transfer factor in stage II malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The augmentation of tumor-specific immunity by virus help. II. Enhanced induction of cytotoxic T lymphocyte and antibody responses to tumor antigens by vaccinia virus-reactive helper T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy for recurrent malignant melanoma: efficacy of BCG in prolonging the postoperative disease-free interval and survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of primary melanoma by intralesional vaccinia before excision

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognosis of skin melanoma with regional node metastases (stage II)

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognosis of patients with pathologic stage II cutaneous malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3677126

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q69442750&oldid=1752418050"